Latest News and Press Releases
Want to stay updated on the latest news?
-
In Q2 2025, Aduro uplisted to Nasdaq, raised $4.52M, partnered with Zeton on a pilot plant, signed a GF MOU for PEX recycling, and showcased tech globally.
-
Aduro Clean Technologies Reports 2024 Financial Results and Provides End of Year Update
-
Aduro announced a new patent filing covering a new technology for transforming renewable oils and certain waste plastics into higher-value BTX chemicals.
-
SARNIA, Ontario, April 11, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
-
SARNIA, Ontario, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
-
SARNIA, Ontario, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
-
SARNIA, Ontario, June 20, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
-
ADVISORY, March 27, 2017 (GLOBE NEWSWIRE) -- What:Aduro Biotech, Inc. (Nasdaq:ADRO), an immunotherapy company focused on the discovery, development and commercialization of therapies that...
-
BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...
-
BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...